Free Republic

The man, Kevin Daly, realized something was wrong when he lost more than 30 lbs. in 2015, but his belly fat didn't budge, the New York Daily News reported earlier this month. A CT scan revealed that the man's belly bulge was in fact a rare type of tumor called a liposarcoma, according to Fox News. ... Liposarcomas most often develop in fat tissue found in the thigh, behind the knee or in the abdomen, GARD says. (Indeed, Daly's tumor arose from fat tissue in his abdomen.)  The tumors are rare; according to the American Cancer Society (ACS), about 13,000...

For the first time ever, three pharmaceutical companies are poised to test whether new drugs can work against a wide range of cancers independently of where they originated — breast, prostate, liver, lung. The drugs go after an aberration involving a cancer gene fundamental to tumor growth. Many scientists see this as the beginning of a new genetic age in cancer research. Great uncertainties remain, but such drugs could mean new treatments for rare, neglected cancers, as well as common ones. Merck, Roche and Sanofi are racing to develop their own versions of a drug they hope will restore a...